Badreddin Edris - 21 Jan 2026 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Jan 2026, 13:34:18 UTC
Prior SEC filing
02 Jul 2025
Next SEC filing
16 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/John R. Moore Attorney-in-Fact for Badreddin Edris

Key filing fact

Badreddin Edris filed Form 4 for Edgewise Therapeutics, Inc. (EWTX) on 23 Jan 2026.

Key facts

  • This page summarizes Badreddin Edris's Form 4 filing for Edgewise Therapeutics, Inc. (EWTX).
  • 15 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 23 Jan 2026, 13:34.

Change

  • Previous filing in this sequence was filed on 02 Jul 2025.
  • Current net transaction value: -$3,229,202.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001786966 Primary reporting owner

Edris Badreddin

Relationship
Director
Address
C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER
Signature
/s/John R. Moore Attorney-in-Fact for Badreddin Edris
Signature date
21 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EWTX transaction

Common Stock

Options Exercise

Transaction value
$5,339
Shares
+13,690
Change %
+69%
Price
$0.3900
Shares after
33,510
Date
21 Jan 2026
Ownership
Direct
EWTX transaction

Common Stock

Options Exercise

Transaction value
$11,031
Shares
+17,236
Change %
+51%
Price
$0.6400
Shares after
50,746
Date
21 Jan 2026
Ownership
Direct
EWTX transaction

Common Stock

Options Exercise

Transaction value
$20,194
Shares
+10,463
Change %
+21%
Price
$1.93
Shares after
61,209
Date
21 Jan 2026
Ownership
Direct
EWTX transaction

Common Stock

Options Exercise

Transaction value
$128,301
Shares
+66,477
Change %
+109%
Price
$1.93
Shares after
127,686
Date
21 Jan 2026
Ownership
Direct
EWTX transaction

Common Stock

Options Exercise

Transaction value
$5,400
Shares
+7,605
Change %
+6%
Price
$0.7100
Shares after
135,291
Date
21 Jan 2026
Ownership
Direct
EWTX transaction

Common Stock

Sale

Transaction value
$403,034
Shares
-13,690
Change %
-10%
Price
$29.44
Shares after
121,601
Date
21 Jan 2026
Ownership
Direct
Footnotes
F1, F2
EWTX transaction

Common Stock

Sale

Transaction value
$507,428
Shares
-17,236
Change %
-14%
Price
$29.44
Shares after
104,365
Date
21 Jan 2026
Ownership
Direct
Footnotes
F1, F2
EWTX transaction

Common Stock

Sale

Transaction value
$223,891
Shares
-7,605
Change %
-7.3%
Price
$29.44
Shares after
96,760
Date
21 Jan 2026
Ownership
Direct
Footnotes
F1, F2
EWTX transaction

Common Stock

Sale

Transaction value
$308,031
Shares
-10,463
Change %
-11%
Price
$29.44
Shares after
86,297
Date
21 Jan 2026
Ownership
Direct
Footnotes
F1, F2
EWTX transaction

Common Stock

Sale

Transaction value
$1,957,083
Shares
-66,477
Change %
-77%
Price
$29.44
Shares after
19,820
Date
21 Jan 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EWTX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-10,463
Change %
-100%
Price
$0.000000
Shares after
0
Date
21 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,463
Exercise price
$1.93
EWTX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-66,477
Change %
-100%
Price
$0.000000
Shares after
0
Date
21 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
66,477
Exercise price
$1.93
EWTX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-7,605
Change %
-100%
Price
$0.000000
Shares after
0
Date
21 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,605
Exercise price
$0.7100
EWTX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-17,236
Change %
-100%
Price
$0.000000
Shares after
0
Date
21 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,236
Exercise price
$0.6400
EWTX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-13,690
Change %
-100%
Price
$0.000000
Shares after
0
Date
21 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,690
Exercise price
$0.3900
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 24, 2025.

Footnote F2

The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.77, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .